Director's Update

DMARDs Effective in Treating Juvenile Arthritis

• AHRQ comparative effectiveness report on treating juvenile arthritis:
  • Affects up to 400 of every 100,000 children in the USA.
  • Development of disease-modifying anti-rheumatic drugs (DMARDs) has improved treatment of arthritis.
  • DMARDs more effective than traditional treatments in improving symptoms.
  • Long-term effects unknown.

http://www.effectivehealthcare.ahrq.gov

Image: The cover of the DMARDs report is shown.

Previous Slide         Contents         Next Slide